Opendata, web and dolomites

Fertissimo SIGNED

A ground-breaking medical system selecting the most viable embryo for successful IVF pregnancy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Fertissimo project word cloud

Explore the words cloud of the Fertissimo project. It provides you a very rough idea of what is the project "Fertissimo" about.

standard    predict    fertissimo    efficient    utilises    qualify    series    stress    valencia    prospective    diagnostics    medical    chances    unable    oxidative    25    legacy    media    pregnancies    unprecedented    manner    soon    viability    practiced    forming    ivf    solid    os    procedure    invasive    mass    finances    riskier    dependable    morphology    industrially    engineering    facilities    leader    low    aran    global    tools    validation    carmel    minimise    excellence    create    benefit    risk    costly    clinical    conduct    company    profile    biomarker    single    quantitative    foundation    multiple    qualified    hospitals    joins    transfer    clinics    rates    forces    ultimate    2009    trial    accurate    centres    incubated    retrospective    met    culture    reproductive    pregnancy    certify    embryo    embryos    qualities    equates    rapid    innovation    lay    line    basis    infrastructure    conclusive    rate    accommodate    gold    mothers    physician    ivi    located    outcomes   

Project "Fertissimo" data sheet

The following table provides information about the project.

Coordinator
CARMEL DIAGNOSTICS LTD 

Organization address
address: 9 BARLEV HAIM STREET
city: QIRYAT TIVON
postcode: 3608267
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.fertissimoivf.com
 Total cost 2˙751˙973 €
 EC max contribution 2˙711˙973 € (99%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARMEL DIAGNOSTICS LTD IL (QIRYAT TIVON) coordinator 1˙446˙486.00
2    ARAN RESEARCH DEVELOPMENT & PROTOTYPES LTD IL (CAESAEA) participant 1˙265˙487.00

Map

 Project objective

Low rates of pregnancy in IVF procedure is due to being unable to identify viable embryos for transfer. As a result, multiple embryo transfer (MET) is practiced to increase the chances of pregnancy. This is a costly procedure with riskier outcomes, which on average only equates to a 1 out of 4 rate of pregnancy success. In order to minimise the cost and risk outcomes with MET, there are increasing trends have been adopted to accommodate single embryo transfer (SET). SET however, requires more efficient embryo selection tools than current legacy morphology methods.

Fertissimo utilises a novel biomarker of oxidative stress (OS) qualities that will enable the physician’s selection of viable embryos in a rapid, non-invasive, and accurate manner. Fertissimo will provide a quantitative assessment of an embryo’s reproductive potential based on the oxidative profile of its incubated culture media. It will increase IVF pregnancy outcomes by an unprecedented 25% and beyond.

The Phase 2 project’s ultimate aim is to lay the foundation for dependable IVF pregnancies of the future. Fertissimo will set the gold standard for IVF procedure in all relevant IVF facilities, located in hospitals, medical centres, centres of IVF excellence, and clinics. Carmel Diagnostics will conduct a series of clinical validation studies, both retrospective and prospective, in order to qualify the novel OS biomarker to effectively predict embryo viability

Carmel Diagnostics (established in 2009) joins forces with Aran R&D, a leading engineering and product development company, forming a solid basis with all necessary knowledge capabilities, infrastructure and finances to support the innovation project. This would allow Carmel, and Aran, to develop, test, certify, and create the production line required for Fertissimo’s mass production.

The industrially produced Fertissimo can then be qualified in a conclusive clinical trial with Global IVF Leader IVI Valencia to the benefit of soon-to-be mothers

 Deliverables

List of deliverables.
Original Investor Relations Kit Dossier Websites, patent fillings, videos etc. 2019-03-20 11:46:21
Project website Websites, patent fillings, videos etc. 2019-03-20 11:46:21

Take a look to the deliverables list in detail:  detailed list of Fertissimo deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FERTISSIMO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FERTISSIMO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

SBR (2020)

SMART BONE REGENERATION

Read More